Hope for diabetes: CRISPR-edited cells evade immune detection

Elie Dolgin • September 5, 2025

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the need for the recipient to take immune-dampening drugs, thanks to gene edits that allowed the cells, collected from a deceased donor, to evade detection by the recipient’s immune system.


Continue reading at Nature.

By Elie Dolgin September 25, 2025
Language model delivers predictions that rival years of lab work.
Man in military uniform administering a vaccine into the arm of another man.
By Elie Dolgin September 24, 2025
The Department of Defense is continuing to bankroll projects to develop vaccines against deadly pathogens.